Baird raised the firm’s price target on UnitedHealth (UNH) to $287 from $278 and keeps an Underperform rating on the shares. The firm updated its model following its beat and raise Q1 results where Optum Health appears fine but Insight remains concerning.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH: